Related Experiment Video
Updated: Apr 21, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
PET imaging of bacterial infections with fluorine-18-labeled maltohexaose
Xinghai Ning1, Wonewoo Seo2, Seungjun Lee1
1Department of Bioengineering, UC Berkeley, 284 Hearst Memorial Mining Building, UC Berkeley, Berkeley, CA 94720 (USA).
Abstract:
A positron emission tomography (PET) tracer composed of (18)F-labeled maltohexaose (MH(18)F) can image bacteria in vivo with a sensitivity and specificity that are orders of magnitude higher than those of fluorodeoxyglucose ((18)FDG). MH(18)F can detect early-stage infections composed of as few as 10(5) E. coli colony-forming units (CFUs), and can identify drug resistance in bacteria in vivo. MH(18)F has the potential to improve the diagnosis of bacterial infections given its unique combination of high specificity and sensitivity for bacteria.
Insights
A novel positron emission tomography (PET) tracer, (18)F-labeled maltohexaose (MH(18)F), offers superior sensitivity and specificity for detecting bacterial infections in vivo compared to (18)FDG. This tracer can identify early infections and antibiotic resistance, improving diagnostic capabilities.
Area of Science:
- Medical Imaging
- Nuclear Medicine
- Microbiology
Background:
- Bacterial infections pose a significant global health challenge.
- Current diagnostic methods for bacterial infections often lack sufficient sensitivity and specificity.
- Fluorodeoxyglucose ((18)FDG) PET imaging has limitations in bacterial infection detection.
Purpose of the Study:
- To evaluate the efficacy of a novel (18)F-labeled maltohexaose (MH(18)F) PET tracer for in vivo bacterial imaging.
- To compare the diagnostic performance of MH(18)F with (18)FDG for bacterial infections.
- To assess the potential of MH(18)F in detecting early-stage infections and antibiotic resistance.
Main Methods:
- Development and characterization of (18)F-labeled maltohexaose (MH(18)F) as a PET tracer.
- In vivo imaging studies using MH(18)F to detect bacterial infections.
- Comparison of MH(18)F imaging with standard methods, including (18)FDG PET, in preclinical models.
- Assessment of MH(18)F sensitivity for low bacterial loads and identification of drug-resistant strains.
Main Results:
- MH(18)F demonstrated significantly higher sensitivity and specificity for bacterial imaging compared to (18)FDG.
- The tracer successfully detected early-stage infections with as few as 10(5) E. coli colony-forming units (CFUs).
- MH(18)F enabled in vivo identification of bacterial drug resistance.
Conclusions:
- (18)F-labeled maltohexaose (MH(18)F) is a highly sensitive and specific PET tracer for in vivo bacterial imaging.
- MH(18)F offers a promising advancement for the early diagnosis of bacterial infections.
- This novel tracer has the potential to revolutionize the management of infectious diseases by enabling rapid detection of infections and antibiotic resistance.
More Related Videos
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Immunofluorescence Microscopy

